XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Total Common Shareholders' Equity
Noncontrolling Interests
Beginning Balance (in shares) at Dec. 31, 2022   13,673,064            
Beginning Balance at Dec. 31, 2022 $ 1,254,028 $ 195 $ 1,044,719 $ 453,311 $ (441,653) $ (2,499) $ 1,054,073 $ 199,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 98,973     85,491     85,491 13,482
Dividends (84,444)     (84,444)     (84,444)  
Amortization/issuance of restricted stock (1) $ 98,285   98,285       98,285  
Repurchase of common stock through share repurchase program (in shares) 0              
Repurchase of common stock through share repurchase program $ 0              
Issuance of treasury shares for restricted stock vestings (in shares)   2,013,046            
Issuance of treasury shares for restricted stock vestings $ 0   (156,036)   156,036   0  
Repurchase of common stock from employees (in shares) (494,555) (494,555)            
Repurchase of common stock from employees $ (70,680)       (70,680)   (70,680)  
Shares reserved/issued for director compensation (in shares)   8,594            
Shares reserved/issued for director compensation 1,168   1,168       1,168  
Other comprehensive income/(loss) 1,605         1,605 1,605  
Fund capital contributions/(distributions), net 538           0 538
Ending Balance (in shares) at Dec. 31, 2023   15,200,149            
Ending Balance at Dec. 31, 2023 1,299,473 $ 195 988,136 454,358 (356,297) (894) 1,085,498 213,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 157,440     181,114     181,114 (23,674)
Dividends (73,726)     (73,726)     (73,726)  
Amortization/issuance of restricted stock (1) $ 93,801   93,801       93,801  
Repurchase of common stock through share repurchase program (in shares) 0              
Repurchase of common stock through share repurchase program $ 0              
Issuance of treasury shares for options exercised (in shares)   8,000            
Issuance of treasury shares for options exercised 792   75   717   792  
Issuance of treasury shares for restricted stock vestings (in shares)   1,224,008            
Issuance of treasury shares for restricted stock vestings 0   (105,384)   105,384   0  
Issuance of treasury shares for acquisitions (in shares)   21,835            
Issuance of treasury shares for acquisitions $ 5,982   4,016   1,966   5,982  
Repurchase of common stock from employees (in shares) (346,972) (346,972)            
Repurchase of common stock from employees $ (66,426)       (66,426)   (66,426)  
Shares reserved/issued for director compensation (in shares)   4,703            
Shares reserved/issued for director compensation 1,080   1,080       1,080  
Other comprehensive income/(loss) (285)         (285) (285)  
Fund capital contributions/(distributions), net (2,358)           0 (2,358)
Ending Balance (in shares) at Dec. 31, 2024   16,111,723            
Ending Balance at Dec. 31, 2024 1,415,773 $ 195 981,724 561,746 (314,656) (1,179) 1,227,830 187,943
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 293,965     281,331     281,331 12,634
Dividends (114,146)     (114,146)     (114,146)  
Amortization/issuance of restricted stock (1) $ 91,558   91,558       91,558  
Repurchase of common stock through share repurchase program (in shares) (101,903) (101,903)            
Repurchase of common stock through share repurchase program $ (28,436)       (28,436)   (28,436)  
Issuance of treasury shares for options exercised (in shares)   42,900            
Issuance of treasury shares for options exercised 4,247   (402)   4,649   4,247  
Issuance of treasury shares for restricted stock vestings (in shares)   1,132,014            
Issuance of treasury shares for restricted stock vestings $ 0   (116,469)   116,469   0  
Repurchase of common stock from employees (in shares) (318,801) (318,801)            
Repurchase of common stock from employees $ (96,607)       (96,607)   (96,607)  
Shares reserved/issued for director compensation (in shares)   4,925            
Shares reserved/issued for director compensation 1,318   1,318       1,318  
Other comprehensive income/(loss) 3,912         3,912 3,912  
Fund capital contributions/(distributions), net 11,209           0 11,209
Ending Balance (in shares) at Dec. 31, 2025   16,870,858            
Ending Balance at Dec. 31, 2025 $ 1,582,793 $ 195 $ 957,729 $ 728,931 $ (318,581) $ 2,733 $ 1,371,007 $ 211,786